Intelligencer
The Cut
Vulture
The Strategist
Curbed
Grub Street
Magazine
Subscribe to the Magazine
Give a Gift Subscription
Buy Back Issues
Current Issue Contents
New York
Shop
Subscribe
Sign In
Account
Profile
Sign Out
Subscribe
Give A
Gift
Displaying all articles tagged:
Moderna
plagued
Sept. 2, 2022
What to Know About the New COVID Booster Shots
Reformulated booster shots have arrived. Here’s how they are different and who can get them.
By
Chas Danner
explainer
Mar. 30, 2022
What We Know About Second COVID Booster Shots
Americans over 50 are now eligible for an extra dose of COVID-19 vaccine. But experts are still debating who should get one.
By
Chas Danner
covid-19
Mar. 23, 2022
Moderna Says Its COVID Vaccine Works in Kids Under 6
The company plans to seek FDA authorization in the coming weeks, though the shot’s modest efficacy against symptomatic COVID-19 could cause delays.
By
Margaret Hartmann
covid vaccines
Nov. 10, 2021
The NIH and Moderna Are Fighting Over Who Owns Their Vaccine
A patent dispute over the Moderna shot could have serious ramifications for the future distribution of the mRNA vaccine.
By
Matt Stieb
covid-19
Oct. 22, 2021
Booster Shots Are Now Approved for All of the COVID Vaccines
Additional dose recommended for all with J&J and many who got Moderna, with “mix and match” allowed for all varieties.
By
Nia Prater
covid-19
June 24, 2021
Feds Adding Warning to Pfizer, Moderna Shots Over Rare Heart Condition
The CDC has so far confirmed 323 cases of the condition in people ages 12 through 29, but patients generally recovered from the symptoms.
By
Paola Rosa-Aquino
side effects
June 11, 2021
CDC Flags Rare Cases of Heart Swelling in Young People After COVID Jab
Reported myocarditis cases make up a tiny fraction of the nearly 130 million Americans who have had both doses of the Pfizer or Moderna vaccine.
By
Paola Rosa-Aquino
covid-19 vaccine
Mar. 1, 2021
Catholic Archdiocese Bans COVID Vaccine Over Tenuous Link to Abortion
The ruling would be right at home in the Middle Ages.
By
Ed Kilgore
explainer
Dec. 18, 2020
What We Know About the U.S. COVID-19 Vaccine Distribution Plan
The largest mass-vaccination campaign in American history has begun. This is how it may or may not play out.
By
Chas Danner
and
Matt Stieb
encounter
Dec. 8, 2020
On the Front Lines of Moderna’s Vaccine Program
The past year has been a blur for scientist Mike Smith: “I want my kids to see their grandparents again. It feels like a crushing responsibility.”
By
James D. Walsh
tomorrow
Dec. 7, 2020
We Had the Vaccine the Whole Time
The silver bullet we’ve been waiting for took all of one weekend to design.
By
David Wallace-Wells
covid vaccines
Nov. 30, 2020
Moderna Says First COVID Vaccine Shots Could Be Ready by December 21
The company is seeking emergency authorization for doses it says provide overwhelming protection from the virus.
By
Benjamin Hart
covid-19
Nov. 16, 2020
Moderna Says Its Vaccine Is 94.5 Percent Effective in Early Data
As the U.S. struggles with record COVID-19 case numbers, the light at the end of the tunnel looks to be getting closer.
By
Benjamin Hart
coronavirus
May 18, 2020
Promising Early Stage Vaccine Trial Sends Stocks Soaring
Eight healthy patients who received the vaccine developed antibodies at levels similar to those who’ve recovered from COVID-19.
By
Adam K. Raymond
coronavirus
May 7, 2020
The FDA Has Approved a Coronavirus Vaccine for Phase Two Trial
The company says it could start phase three this summer and bring a vaccine to market by early 2021.
By
Adam K. Raymond